Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Recruiting now · Not applicable
Conditions studied: Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis, Hypercholesterolemia
In brief
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Key facts
- Study ID
- NCT05325034
- Run by
- Stephen Nicholls
- People needed
- 2000
- Starts
- 2022-09-15
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-08-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age
- Admission for Type I myocardial infarction
You may not qualify if…
- LDL <1.4mmol/L at baseline
- Unable to provide contact details of primary care physician/general practitioner
- Unable to provide written informed consent.
- Unlikely to survive >12 months
Where it is running
- Affiliated Zhongshan Hospital of Dalian University — Dalian, Liaoning, China (enrolling)
- National Heart Institute — Kuala Lumpur, Malaysia (enrolling)
- University of Malaysia Medical Centre — Kuala Lumpur, Malaysia (enrolling)
- National Heart Centre — Singapore, Singapore (enrolling)
- All India Institute of Medical Sciences — New Delhi, India (enrolling)
- Cairns & Hinterland Hospital & Health Service — Cairns, Queensland, Australia (enrolling)
- Monash Health — Clayton, Victoria, Australia (enrolling)
- National Cheng Kung University Hospital — Tainan, Taiwan (enrolling)
- National Cerebral and Cardiovascular Center — Osaka, Japan (enrolling)
- Western Health — Melbourne, Victoria, Australia (enrolling)
- Illawarra Shoalhaven Local Health District — Wollongong, New South Wales, Australia (enrolling)
- Songklanagarind Hospital — Songkhla, Thailand
- Flinders Medical Centre — Bedford Park, South Australia, Australia
- Fukuoka University Hospital — Fukuoka, Japan
- Kyorin University Hospital — Mitaka, Japan
- Osaka Medical and Pharmaceutical University Hospital — Osaka, Japan
- University Teknologi MARA, Hospital UiTM, UiTM Medical Centre — Shah Alam, Selangor, Malaysia
- National University Hospital Singapore (NUHS) — Singapore, Singapore
- PyeongChon Hallym University Sacred Heart Hospital — Pyeongchon, Gyeonggi Province, South Korea
- Kangnam Hallym University Sacred Heart Hospital — Seoul, South Korea
- Siriraj Hospital — Bangkok, Thailand
- Srinagarind Hospital and Queen Sirikit Heart Center of the Northeast — Khon Kaen, Thailand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.